Anticancer and Molecular Docking Studies of Novel Heterocyclics

This book explores the development of new heterocyclic compounds with potential anticancer activity. The book includes a detailed account of the synthesis of these compounds and their characterization using various analytical techniques.The anticancer activity of these compounds is evaluated against several cancer cell lines using various in vitro assays. The results of these assays are presented and analyzed, with a focus on identifying the most potent compounds.In addition to the biological evaluation, the book also includes molecular docking studies to investigate the interaction of these compounds with cancer targets at the molecular level. The docking studies provide insights into the possible binding modes of these compounds, which can help in the design of more potent analogs in the future.Overall, it provides a comprehensive overview of the development of new heterocyclic compounds with potential anticancer activity, from synthesis to biological evaluation and molecular docking studies.

Autorentext

Prof. P. Jalapathi is a distinguished chemist and faculty member in the Dept. of Chemistry at Osmania University, India.He obtain Ph.D from Kakatiya University Warangal in 2000. His research focuses on the synthesis of novel organic molecule and their pharmacological and biological screening. He is a dedicated teacher and reviewer of journals.